At Work With: Jen Jonsson

Share this article:
At Work With: Jen Jonsson
At Work With: Jen Jonsson

JEN JONSSON
Director, Operations, Cambridge BioMarketing

What was your biggest break?
I was given an opportunity to lead a digital project that had never been done before. I was running it solo, dealing with people way above my pay grade at the time, and the project was a major success.

What's the best and/or worst part of your job?
Best: Working with our teams  to come up with the best possible solutions for our clients. Connecting patients with rare diseases with life-saving therapies is pretty rewarding.

What's the view like from your office/work area?
I can see the Charles River and the Boston skyline. Love it.

Where did you go to college? Did it help you prepare for your career?
I graduated from The New School. My first job out of school was as an intern for the cover art editor of The New Yorker. I would not be in advertising/marketing today if it weren't for that internship.

What was your greatest professional challenge?
I began in digital in the late 90's. It was the early days and there was a lot to learn!

Where will you be in five years?
Continuing to work with people who inspire me, here at CB.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?